MedTrace Logo

The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression

NCT05713981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-06-26

No results posted yet for this study

Summary

The study aims to determine the impact of Meibomian Gland Dysfunction (MGD) dry eye on low contrast black/white (luminance) and cone color sensitivity performance and improvement in these functions after in-house non-invasive Meibomian gland (MG) expression.

Conditions

  • Meibomian Gland Dysfunction

Interventions

PROCEDURE

Meibomian gland (MG) expression

The procedure is performed with a sterile cotton tip applicator once in the upper and lower eyelids of the subject's choosing.

Sponsors & Collaborators

  • University of the Incarnate Word

    lead OTHER

Principal Investigators

  • Jeffery Rabin, OD, PhD · University of the Incarnate Word

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-06-08
Completion
2023-06-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05713981 on ClinicalTrials.gov